1. Abroms, L., Maibach, E., Lyon-Daniel, K., et al. (2006). What is the best approach to reducing birth defects associated with isotretinoin? PLoS Medicine, 3, e483.
2. Altman, E. M. (2014). Isotretinoin and pregnancy prevention: Do we need to take a long, hard look at ourselves? JAMA Dermatology, 150, 361–362.
3. Atanackovic, G., & Koren, G. (1999a). Fetal exposure to oral isotretinoin: Failure to comply with the Pregnancy Prevention Program. Canadian Medical Association Journal, 160, 1719–1720.
4. Atanackovic, G., & Koren, G. (1999b). Young women taking isotretinoin still conceive. Role of physicians in preventing disaster. Canadian Family Physician, 45, 289–292.
5. Braun, J. T., Franciosi, R. A., Mastri, A. R., et al. (1984). Isotretinoin dysmorphic syndrome. Lancet, 1, 506–507.